RGLS
Regulus Therapeutics Inc.
Director Stelios Papadopoulos bought $681K of Regulus Therapeutics Inc.
Bought$680,550
$1.36Price
500,000Shares
+296%Stake
What RGLS did for a copier
Prices for RGLS after this filing aren't in yet.
Stelios Papadopoulos's record
5 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Nov 15. Filed Mon, Nov 19, 4:03 PM ET, after the close. Not investment advice.